Showing results (721-730 of 991) with videos related to

Sort By:
Pageof 100
Assay and Drug Development Technologies|December 16, 2014
Bioluminescent cell-based NAD(P)/NAD(P)H assays for rapid dinucleotide measurement and inhibitor screeningJolanta Vidugiriene, Donna Leippe, Mary Sobol, et al.
Assay and Drug Development Technologies|June 25, 2015
Examining Ligand-Based Stabilization of Proteins in Cells with MEK1 Kinase InhibitorsDouglas S Auld, Christopher A Davis, Marta Jimenez, et al.
Assay and Drug Development Technologies|February 8, 2011
Development and utilization of activated STAT3 detection assays for screening a library of secreted proteinsNatalie Fursov, Irina V Gates, Tadas Panavas, et al.
Assay and Drug Development Technologies|December 17, 2010
Triphenylphosphine oxide is a potent and selective inhibitor of the transient receptor potential melastatin-5 ion channelR Kyle Palmer, Karnail Atwal, Ivona Bakaj, et al.
Assay and Drug Development Technologies|December 28, 2010
Functional drug screening assay reveals potential glioma therapeuticsChristian E Badr, Thomas Wurdinger, Bakhos A Tannous
Assay and Drug Development Technologies|December 8, 2010
Exchange protein directly activated by cyclic AMP isoform 2 is not a direct target of sulfonylurea drugsTamara Tsalkova, Alexey V Gribenko, Xiaodong Cheng
Assay and Drug Development Technologies|December 8, 2010
Characterization of selective ubiquitin and ubiquitin-like protease inhibitors using a fluorescence-based multiplex assay formatXufan Tian, Nigora S Isamiddinova, Raymond J Peroutka, et al.
Assay and Drug Development Technologies|December 8, 2010
Cardiac ion channel safety profiling on the IonWorks Quattro automated patch clamp systemXueying Cao, Yan Tony Lee, Mats Holmqvist, et al.
Assay and Drug Development Technologies|October 27, 2010
High-content assay to identify inhibitors of dengue virus infectionDavid Shum, Jessica L Smith, Alec J Hirsch, et al.
Assay and Drug Development Technologies|June 3, 2010
A high-throughput screening compatible assay for activators and inhibitors of methionine sulfoxide reductase ADavid Brunell, Herbert Weissbach, Peter Hodder, et al.
Pageof 100